Cogimpa, a Webionz.com project by Fidel Olivieri Logo
    • 高级搜索
  • 来宾
    • 登录
    • 登记
    • 夜间模式
emmaverghise Cover Image
User Image
拖动以重新放置封面
emmaverghise Profile Picture
emmaverghise

@emmaverghise

  • 时间线
  • 团体
  • 喜欢
  • 下列的
  • 追随者
  • 相片
  • 视频
  • 卷轴
emmaverghise profile picture emmaverghise profile picture
emmaverghise
13 小时

The U.S. nutrigenomics market reached USD 185.06 million in 2024 and is forecast to grow at a CAGR of 17.6% through 2034, reflecting the field’s entrenched position in mainstream healthcare, wellness, and preventative medicine. While the United States remains the dominant force globally, countries such as China, Germany, and South Korea are playing pivotal roles in shaping the industry’s trajectory. National policy impact, market share concentration, R&D leadership, and strategic positioning are increasingly influential in determining corporate success amid rising global competition and shifting geopolitical dynamics.
In the U.S., federal agencies such as the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) continue to drive regulatory frameworks that support the scientific validation and clinical adoption of nutrigenomic testing. The Bipartisan Infrastructure Law and recent updates to the 21st Century Cures Act have catalyzed new capital investments from major players like Quest Diagnostics, Thermo Fisher Scientific, and Nutrigenomix, who are expanding testing capacities and integrating AI-based interpretation tools. Strategic acquisitions—such as LabCorp’s acquisition of Personalized Nutrition and ZOE’s partnership with King’s College London—are consolidating market share and reinforcing the dominance of established players in both research and commercialization phases.
China has emerged as a formidable contender, with state-backed programs like the Precision Medicine Initiative and Made in China 2025 strategy supporting domestic innovation in nutrigenomics. BGI Genomics and Wuxi AppTec are aggressively scaling up their capabilities in population genetics and bioinformatics, often partnering with Western diagnostics firms to access global markets. Trade policies and export controls, however, remain a source of uncertainty, prompting some multinational corporations to diversify their supply chains and establish satellite labs in Southeast Asia.
Read More @ https://www.polarismarketresea....rch.com/industry-ana
Germany stands out for its methodical approach to nutrigenomics, characterized by strong collaboration between academia, industry, and regulatory bodies. The Max Planck Institute and University Hospital Heidelberg play instrumental roles in translating basic research into commercial applications, while companies like Qiagen and Eurofins Genomics are investing heavily in next-generation sequencing platforms and proprietary SNP databases. The country’s emphasis on quality control and process standardization makes it a preferred location for setting up centralized testing laboratories catering to European and global clients.
Corporate strategies among top-tier players are increasingly centered around geographic expansion, vertical integration, and technology leadership. Major firms are not only acquiring boutique analytics shops but also building internal capabilities in machine learning, digital therapeutics, and remote patient monitoring to enhance system reliability and customer satisfaction. Market share concentration remains moderate, with the top five companies accounting for approximately 57% of total revenue, although niche players specializing in specific disease pathways or ethnic populations are gaining traction in targeted therapeutic areas.
R&D leadership is concentrated among a few dominant players who invest heavily in multi-omics integration, population-specific biomarkers, and AI-enhanced dietary modeling designed to improve clinical relevance and scalability. Strategic positioning is also influenced by patent portfolios and participation in international consortia, which provide leverage in licensing negotiations and market access discussions. As the nutrigenomics market matures, companies that align their innovation pipelines with macroeconomic shifts and policy imperatives will be best positioned to capitalize on the long-term tailwinds shaping the future of personalized nutrition.
Dominant Players by Market Share:
• Nutrigenomix Inc.
• DNAfit Ltd.
• Pathway Genomics Corporation
• Quest Diagnostics Incorporated
• BGI Genomics Co., Ltd.
• Thermo Fisher Scientific Inc.
• MyDNA Life Inc.
• ZOE Inc.
More Trending Latest Reports By Polaris Market Research:
Cladding Systems Market
Robot Charging Station Market
Ultrasonic Air Bubble Detectors Market
Healthcare It Market
Tiki Torch Market
Healthy Snacks Market
Lipid Regulators Market
Superfoods Market
Electric Kick Scooters Market

U.S. Nutrigenomics Market Size, Value & Share Analysis [2034]
www.polarismarketresearch.com

U.S. Nutrigenomics Market Size, Value & Share Analysis [2034]

U.S. Nutrigenomics Market in terms of revenue was estimated to be worth USD 185.06 million in 2024 and exhibiting a CAGR of 17.6% by 2034
喜欢
评论
分享
emmaverghise profile picture emmaverghise profile picture
emmaverghise 更改了她的头像
13 小时

image
喜欢
评论
分享
 加载更多帖子
    信息
    • 女性
    • 帖子 2
    相册 
    (0)
    下列的 
    (0)
    追随者 
    (2)
    喜欢 
    (0)
    团体 
    (0)

© {日期} Cogimpa, a Webionz.com project by Fidel Olivieri

语

  • 关于
  • 目录
  • 博客
  • 联系我们
  • 开发者
  • 更多的
    • 隐私政策
    • 使用条款
    • 要求退款

取消好友

您确定要取消好友关系吗?

举报该用户

重要的!

您确定要从您的家庭中删除此成员吗?

你戳了 Emmaverghise

新成员已成功添加到您的家庭列表中!

裁剪你的头像

avatar

© {日期} Cogimpa, a Webionz.com project by Fidel Olivieri

  • 家
  • 关于
  • 联系我们
  • 隐私政策
  • 使用条款
  • 要求退款
  • 博客
  • 开发者
  • 语

© {日期} Cogimpa, a Webionz.com project by Fidel Olivieri

  • 家
  • 关于
  • 联系我们
  • 隐私政策
  • 使用条款
  • 要求退款
  • 博客
  • 开发者
  • 语

评论报告成功。

帖子已成功添加到您的时间线!

您已达到 5000 个好友的上限!

文件大小错误:文件超出允许的限制(92 MB),无法上传。

您的视频正在处理中,我们会在可以观看时通知您。

无法上传文件:不支持此文件类型。

我们在您上传的图片中检测到一些成人内容,因此我们拒绝了您的上传过程。

在群组中分享帖子

分享到页面

分享给用户

您的帖子已提交,我们将尽快审核您的内容。

要上传图片、视频和音频文件,您必须升级为专业会员。 升级到专业版

编辑报价

0%

添加层








选择一张图片
删除您的等级
确定要删除此层吗?

评论

为了销售您的内容和帖子,请首先创建一些包。 货币化

钱包支付

添加套餐

删除您的地址

您确定要删除此地址吗?

删除您的获利套餐

您确定要删除这个包吗?

退订

您确定要取消订阅该用户吗?请记住,您将无法查看他们的任何获利内容。

付款提醒

您即将购买商品,是否要继续?
要求退款

语

  • Arabic
  • Bengali
  • Chinese
  • Croatian
  • Danish
  • Dutch
  • English
  • Filipino
  • French
  • German
  • Hebrew
  • Hindi
  • Indonesian
  • Italian
  • Japanese
  • Korean
  • Persian
  • Portuguese
  • Russian
  • Spanish
  • Swedish
  • Turkish
  • Urdu
  • Vietnamese